The role of CXC chemokines as regulators of angiogenesis
- PMID: 8574748
- DOI: 10.1097/00024382-199509000-00001
The role of CXC chemokines as regulators of angiogenesis
Abstract
The regulation of angiogenesis is fundamental to a variety of physiological and pathological processes. Although a number of factors have been identified that induce neovascularization, it is becoming increasingly apparent that endogenous angiostatic factors may play an important role in the regulation of angiogenesis during wound repair, chronic inflammation, and growth of solid tumors. In this review, we demonstrate that the CXC chemokine family of cytokines display disparate angiogenic activity depending upon the presence or absence of the ELR motif, a structural amino acid motif previously found to be important in receptor ligand binding on neutrophils. CXC chemokines containing the ELR motif are potent angiogenic factors, inducing both in vitro endothelial chemotaxis and in vivo corneal neovascularization. In contrast, the CXC chemokines that lack the ELR motif, PF4, IP-10, and MIG, not only fail to induce significant in vitro endothelial cell chemotaxis or in vivo corneal neovascularization, but are found to be potent angiostatic factors in the presence of CXC chemokines containing the ELR motif. These findings suggest that the CXC chemokine family can display disparate angiogenic activity that depends upon the presence or absence of the ELR motif. Furthermore, these studies support the notion that the net biological balance in the magnitude of expression of angiogenic and angiostatic CXC chemokines at either the site of wound repair or during tumorigenesis may be important in the regulation of net angiogenesis.
Similar articles
-
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.J Biol Chem. 1995 Nov 10;270(45):27348-57. doi: 10.1074/jbc.270.45.27348. J Biol Chem. 1995. PMID: 7592998
-
The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.Hum Gene Ther. 2000 Jan 20;11(2):247-61. doi: 10.1089/10430340050015996. Hum Gene Ther. 2000. PMID: 10680839
-
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.J Immunol. 2000 Nov 1;165(9):5269-77. doi: 10.4049/jimmunol.165.9.5269. J Immunol. 2000. PMID: 11046061
-
CXC chemokines in angiogenesis.Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609. doi: 10.1016/j.cytogfr.2005.04.007. Epub 2005 Jul 19. Cytokine Growth Factor Rev. 2005. PMID: 16046180 Review.
-
CXC chemokines in angiogenesis relevant to chronic fibroproliferation.Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):23-6. doi: 10.2174/1568010053622902. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720231 Review.
Cited by
-
Chemokines: novel targets for breast cancer metastasis.Cancer Metastasis Rev. 2007 Dec;26(3-4):401-20. doi: 10.1007/s10555-007-9073-z. Cancer Metastasis Rev. 2007. PMID: 17717637 Free PMC article. Review.
-
Chemokines in health and disease.Exp Cell Res. 2011 Mar 10;317(5):575-89. doi: 10.1016/j.yexcr.2011.01.005. Epub 2011 Jan 9. Exp Cell Res. 2011. PMID: 21223965 Free PMC article. Review.
-
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.Br J Cancer. 2006 Jun 19;94(12):1845-52. doi: 10.1038/sj.bjc.6603186. Epub 2006 May 23. Br J Cancer. 2006. PMID: 16721359 Free PMC article.
-
Chemokines and cardiac fibrosis.Front Biosci (Schol Ed). 2009 Jun 1;1(2):391-405. doi: 10.2741/s33. Front Biosci (Schol Ed). 2009. PMID: 19482709 Free PMC article. Review.
-
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.Cancer Immunol Immunother. 2016 Oct;65(10):1189-99. doi: 10.1007/s00262-016-1881-y. Epub 2016 Aug 13. Cancer Immunol Immunother. 2016. PMID: 27522581 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous